• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于药效团的深度学习方法用于生物活性分子生成。

A pharmacophore-guided deep learning approach for bioactive molecular generation.

机构信息

School of Computer Science and Engineering, Central South University, Changsha, 410083, China.

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410008, China.

出版信息

Nat Commun. 2023 Oct 6;14(1):6234. doi: 10.1038/s41467-023-41454-9.

DOI:10.1038/s41467-023-41454-9
PMID:37803000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10558534/
Abstract

The rational design of novel molecules with the desired bioactivity is a critical but challenging task in drug discovery, especially when treating a novel target family or understudied targets. We propose a Pharmacophore-Guided deep learning approach for bioactive Molecule Generation (PGMG). Through the guidance of pharmacophore, PGMG provides a flexible strategy for generating bioactive molecules. PGMG uses a graph neural network to encode spatially distributed chemical features and a transformer decoder to generate molecules. A latent variable is introduced to solve the many-to-many mapping between pharmacophores and molecules to improve the diversity of the generated molecules. Compared to existing methods, PGMG generates molecules with strong docking affinities and high scores of validity, uniqueness, and novelty. In the case studies, we use PGMG in a ligand-based and structure-based drug de novo design. Overall, the flexibility and effectiveness make PGMG a useful tool to accelerate the drug discovery process.

摘要

设计具有预期生物活性的新型分子是药物发现中的一项关键但具有挑战性的任务,尤其是在针对新型靶标家族或研究较少的靶标时。我们提出了一种基于药效团的深度学习方法用于生物活性分子生成(PGMG)。通过药效团的指导,PGMG 为生成生物活性分子提供了一种灵活的策略。PGMG 使用图神经网络来编码空间分布的化学特征,并使用转换器解码器来生成分子。引入了一个潜在变量来解决药效团和分子之间的多对多映射问题,以提高生成分子的多样性。与现有方法相比,PGMG 生成的分子具有较强的对接亲和力和较高的有效性、独特性和新颖性得分。在案例研究中,我们在基于配体和基于结构的药物从头设计中使用了 PGMG。总体而言,其灵活性和有效性使 PGMG 成为加速药物发现过程的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/cc8794fc6299/41467_2023_41454_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/7a20d63901b0/41467_2023_41454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/73cbb2e218a1/41467_2023_41454_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/8070c9e29410/41467_2023_41454_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/f9297029cf98/41467_2023_41454_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/0c0cb883f86a/41467_2023_41454_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/68d94253f8a8/41467_2023_41454_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/cc8794fc6299/41467_2023_41454_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/7a20d63901b0/41467_2023_41454_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/73cbb2e218a1/41467_2023_41454_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/8070c9e29410/41467_2023_41454_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/f9297029cf98/41467_2023_41454_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/0c0cb883f86a/41467_2023_41454_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/68d94253f8a8/41467_2023_41454_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4ca/10558534/cc8794fc6299/41467_2023_41454_Fig7_HTML.jpg

相似文献

1
A pharmacophore-guided deep learning approach for bioactive molecular generation.基于药效团的深度学习方法用于生物活性分子生成。
Nat Commun. 2023 Oct 6;14(1):6234. doi: 10.1038/s41467-023-41454-9.
2
FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.FSM-DDTR:使用变压器的多目标从头药物设计的端到端反馈策略。
Comput Biol Med. 2023 Sep;164:107285. doi: 10.1016/j.compbiomed.2023.107285. Epub 2023 Jul 31.
3
Strategies for Design of Molecular Structures with a Desired Pharmacophore Using Deep Reinforcement Learning.使用深度强化学习设计具有所需药效团的分子结构的策略。
Chem Pharm Bull (Tokyo). 2020;68(3):227-233. doi: 10.1248/cpb.c19-00625.
4
MTMol-GPT: De novo multi-target molecular generation with transformer-based generative adversarial imitation learning.MTMol-GPT:基于生成式对抗模仿学习的新型多靶点分子生成
PLoS Comput Biol. 2024 Jun 26;20(6):e1012229. doi: 10.1371/journal.pcbi.1012229. eCollection 2024 Jun.
5
Deep Generation Model Guided by the Docking Score for Active Molecular Design.基于对接评分的深度生成模型在活性分子设计中的应用。
J Chem Inf Model. 2023 May 22;63(10):2983-2991. doi: 10.1021/acs.jcim.3c00572. Epub 2023 May 10.
6
De Novo Drug Design Using Transformer-Based Machine Translation and Reinforcement Learning of an Adaptive Monte Carlo Tree Search.基于Transformer的机器翻译和自适应蒙特卡罗树搜索强化学习的从头药物设计
Pharmaceuticals (Basel). 2024 Jan 27;17(2):161. doi: 10.3390/ph17020161.
7
Integrating pharmacophore model and deep learning for activity prediction of molecules with BRCA1 gene.基于药效团模型和深度学习的 BRCA1 基因靶标分子活性预测
J Bioinform Comput Biol. 2024 Feb;22(1):2450003. doi: 10.1142/S0219720024500033.
8
RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design.关系:一种基于结构的从头药物设计的深度生成模型。
J Med Chem. 2022 Jul 14;65(13):9478-9492. doi: 10.1021/acs.jmedchem.2c00732. Epub 2022 Jun 17.
9
Comparison of structure- and ligand-based scoring functions for deep generative models: a GPCR case study.深度生成模型中基于结构和配体的评分函数比较:以G蛋白偶联受体为例的研究
J Cheminform. 2021 May 13;13(1):39. doi: 10.1186/s13321-021-00516-0.
10
De novo generation of dual-target ligands using adversarial training and reinforcement learning.使用对抗训练和强化学习生成双靶配体。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab333.

引用本文的文献

1
Hot-Spot-Guided Generative Deep Learning for Drug-Like PPI Inhibitor Design.用于类药物蛋白质-蛋白质相互作用抑制剂设计的热点引导生成式深度学习
Interdiscip Sci. 2025 Sep 2. doi: 10.1007/s12539-025-00756-w.
2
Optimizing blood-brain barrier permeability in KRAS inhibitors: A structure-constrained molecular generation approach.优化KRAS抑制剂的血脑屏障通透性:一种结构受限的分子生成方法。
J Pharm Anal. 2025 Aug;15(8):101337. doi: 10.1016/j.jpha.2025.101337. Epub 2025 May 9.
3
Rag2Mol: structure-based drug design based on retrieval augmented generation.

本文引用的文献

1
ReMODE: a deep learning-based web server for target-specific drug design.ReMODE:一个基于深度学习的用于特定靶点药物设计的网络服务器。
J Cheminform. 2022 Dec 12;14(1):84. doi: 10.1186/s13321-022-00665-w.
2
Exploiting pretrained biochemical language models for targeted drug design.利用预先训练的生化语言模型进行靶向药物设计。
Bioinformatics. 2022 Sep 16;38(Suppl_2):ii155-ii161. doi: 10.1093/bioinformatics/btac482.
3
RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design.关系:一种基于结构的从头药物设计的深度生成模型。
Rag2Mol:基于检索增强生成的基于结构的药物设计。
Brief Bioinform. 2025 May 1;26(3). doi: 10.1093/bib/bbaf265.
4
Bridging chemical space and biological efficacy: advances and challenges in applying generative models in structural modification of natural products.连接化学空间与生物活性:生成模型在天然产物结构修饰中的应用进展与挑战
Nat Prod Bioprospect. 2025 Jun 6;15(1):37. doi: 10.1007/s13659-025-00521-y.
5
DeepDTAGen: a multitask deep learning framework for drug-target affinity prediction and target-aware drugs generation.DeepDTAGen:用于药物-靶点亲和力预测和靶点导向药物生成的多任务深度学习框架。
Nat Commun. 2025 May 30;16(1):5021. doi: 10.1038/s41467-025-59917-6.
6
A deep learning and molecular modeling approach to repurposing Cangrelor as a potential inhibitor of Nipah virus.一种将坎格雷洛重新用作尼帕病毒潜在抑制剂的深度学习和分子建模方法。
Sci Rep. 2025 May 12;15(1):16440. doi: 10.1038/s41598-025-00024-3.
7
MolSnapper: Conditioning Diffusion for Structure-Based Drug Design.MolSnapper:基于结构的药物设计中的条件扩散
J Chem Inf Model. 2025 May 12;65(9):4263-4273. doi: 10.1021/acs.jcim.4c02008. Epub 2025 Apr 18.
8
DiffMC-Gen: A Dual Denoising Diffusion Model for Multi-Conditional Molecular Generation.DiffMC-Gen:用于多条件分子生成的双去噪扩散模型。
Adv Sci (Weinh). 2025 Jun;12(22):e2417726. doi: 10.1002/advs.202417726. Epub 2025 Apr 1.
9
DTIAM: a unified framework for predicting drug-target interactions, binding affinities and drug mechanisms.DTIAM:用于预测药物-靶点相互作用、结合亲和力和药物作用机制的统一框架。
Nat Commun. 2025 Mar 15;16(1):2548. doi: 10.1038/s41467-025-57828-0.
10
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches.G蛋白偶联受体的配体诱导偏向性激活:计算机模拟方法的最新进展与新方向
Molecules. 2025 Feb 25;30(5):1047. doi: 10.3390/molecules30051047.
J Med Chem. 2022 Jul 14;65(13):9478-9492. doi: 10.1021/acs.jmedchem.2c00732. Epub 2022 Jun 17.
4
Deep generative design with 3D pharmacophoric constraints.具有3D药效团约束的深度生成设计。
Chem Sci. 2021 Oct 25;12(43):14577-14589. doi: 10.1039/d1sc02436a. eCollection 2021 Nov 10.
5
Structure-based drug design using 3D deep generative models.使用3D深度生成模型的基于结构的药物设计。
Chem Sci. 2021 Sep 9;12(41):13664-13675. doi: 10.1039/d1sc04444c. eCollection 2021 Oct 27.
6
Sparse Topological Pharmacophore Graphs for Interpretable Scaffold Hopping.用于可解释骨架跳跃的稀疏拓扑药效团图
J Chem Inf Model. 2021 Jul 26;61(7):3348-3360. doi: 10.1021/acs.jcim.1c00409. Epub 2021 Jul 15.
7
SyntaLinker: automatic fragment linking with deep conditional transformer neural networks.SyntaLinker:基于深度条件变压器神经网络的自动片段链接
Chem Sci. 2020 Jul 22;11(31):8312-8322. doi: 10.1039/d0sc03126g.
8
Masked graph modeling for molecule generation.掩蔽图建模用于分子生成。
Nat Commun. 2021 May 26;12(1):3156. doi: 10.1038/s41467-021-23415-2.
9
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.ADMETlab 2.0:一个集成的在线平台,用于准确全面地预测 ADMET 性质。
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14. doi: 10.1093/nar/gkab255.
10
Mol-CycleGAN: a generative model for molecular optimization.Mol-CycleGAN:一种用于分子优化的生成模型。
J Cheminform. 2020 Jan 8;12(1):2. doi: 10.1186/s13321-019-0404-1.